Pilot CAR-T Cells Therapy for Children/Young Adults With CD19+ R/R Leukemia/Lymphoma

Clinical trial NCT05333302 · RECRUITING

Trial details

NCT number: NCT05333302
Sponsor: Belarusian Research Center for Pediatric Oncology, Hematology and Immunology
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

B-cell Acute Lymphoblastic Leukemia Lymphoblastic B-Cell Lymphoma

Start date: 2020-10-26
Primary completion: 2024-12-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.